Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
NCT02346344 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2015-01-27
Summary
A multi-year clinical study to improve tools for measuring the function of insulin-producing beta cells in people with type 2 diabetes mellitus.
Conditions
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
Juvenile Diabetes Research Foundation
collaborator OTHER -
Amylin Pharmaceuticals, LLC.
collaborator INDUSTRY - collaborator INDUSTRY
- collaborator INDUSTRY
- collaborator INDUSTRY
- collaborator INDUSTRY
-
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
collaborator INDUSTRY - collaborator INDUSTRY
-
Foundation for the National Institutes of Health
lead OTHER
Principal Investigators
-
Dennis Ruff, MD · ICON Development Solutions
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
Countries
- United States
Study Locations
More Related Trials
-
A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus
NCT00521378 ·Status: COMPLETED
-
A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
NCT04143802 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
NCT06897475 ·Status: RECRUITING ·Phase: PHASE2
-
In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
NCT00354536 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
NCT00044694 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
NCT00630825 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3305677 in Participants With Type 2 Diabetes
NCT03928379 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY2608204 in Patients With Type 2 Diabetes
NCT01247363 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382
NCT03341013 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3502970 in Participants With Type 2 Diabetes
NCT04426474 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
NCT07112339 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
NCT02119819 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes
NCT04569994 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
NCT04450394 ·Status: COMPLETED ·Phase: PHASE2
-
CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
NCT00635492 ·Status: COMPLETED
-
A Study for Participants With Type 2 Diabetes Mellitus
NCT00871572 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
NCT01774968 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes
NCT02038764 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY2405319 in Participants With Type 2 Diabetes
NCT01869959 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of CT-868 in Type 1 Diabetes Mellitus
NCT06062069 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
NCT04641312 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3209590 in Participants With Type 2 Diabetes
NCT03367377 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
NCT05823948 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY2599506 in Patients With Type 2 Diabetes
NCT01024244 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
NCT00894322 ·Status: COMPLETED ·Phase: PHASE1/PHASE2